98%
921
2 minutes
20
Background: Currently, it is still confused whether preoperative aminotransferase-to-platelet ratio (APRI) and gamma-glutamyl transferase-to-platelet ratio (GPR) can predict microvascular invasion (MVI) in solitary hepatocellular carcinoma (HCC). We aimed to develop and validate a machine-learning integration model for predicting MVI using APRI, GPR and gadoxetic acid disodium (Gd-EOB-DTPA) enhanced MRI.
Methods: A total of 314 patients from XinQiao Hospital of Army Medical University were divided chronologically into training set (n = 220) and internal validation set (n = 94), and recurrence-free survival was determined to follow up after surgery. Seventy-three patients from Chongqing University Three Gorges Hospital and Luzhou People's Hospital served as external validation set. Overall, 387 patients with solitary HCC were analyzed as whole dataset set. Least absolute shrinkage and selection operator, tenfold cross-validation and multivariate logistic regression were used to gradually filter features. Six machine-learning models and an ensemble of the all models (ENS) were built. The area under the receiver operating characteristic curve (AUC) and decision curve analysis were used to evaluate model's performance.
Results: APRI, GPR, HBP ([liver SI‒tumor SI]/liver SI), PLT, peritumoral enhancement, non-smooth margin and peritumoral hypointensity were independent risk factors for MVI. Six machine-learning models showed good performance for predicting MVI in training set (AUCs range, 0.793-0.875), internal validation set (0.715-0.832), external validation set (0.636-0.746) and whole dataset set (0.756-0.850). The ENS achieved the highest AUCs (0.879 vs 0.858 vs 0.839 vs 0.851) in four cohorts with excellent calibration and more net benefit. Subgroup analysis indicated that ENS obtained excellent AUCs (0.900 vs 0.809 vs 0.865 vs 0.908) in HCC >5cm, ≤5cm, ≤3cm and ≤2cm cohorts. Kaplan‒Meier survival curves indicated that ENS achieved excellent stratification for MVI status.
Conclusion: The APRI and GPR may be new potential biomarkers for predicting MVI of HCC. The ENS achieved optimal performance for predicting MVI in different sizes HCC and may aid in the individualized selection of surgical procedures.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10911084 | PMC |
http://dx.doi.org/10.2147/JHC.S449737 | DOI Listing |
Eur J Radiol
August 2025
Department of Medical Ultrasonics, The Eighth Affiliated Hospital of Sun Yat-sen University, No.3025 Shennan Middle Road, Shenzhen 518033, China. Electronic address:
Purpose: To investigate the predictive value of preoperative gadoxetic acid-enhanced quantitative golden-angle radial sparse parallel (GRASP) dynamic MRI for microvascular invasion (MVI) status in hepatocellular carcinoma (HCC).
Methods: This single-institution prospective study included patients with suspected HCC who underwent gadoxetic acid-enhanced GRASP dynamic MRI. Quantitative parameters derived from dynamic MRI of tumor and peritumoral regions, along with clinical and conventional radiological features, were collected.
BMC Gastroenterol
August 2025
Hangzhou Medical College, Hangzhou, Zhejiang, China.
Aim: Microvascular invasion (MVI) is a key risk factor for hepatocellular carcinoma (HCC) recurrence. There is a lack of methods to diagnose MVI preoperatively. The objective of this study was to develop a model for preoperative prediction of MVI in HCC.
View Article and Find Full Text PDFSurg Endosc
August 2025
The First School of Clinical Medicine, Lanzhou University, Lanzhou, 730000, China.
Background: Microvascular invasion (MVI) is a crucial risk factor for postoperative recurrence in patients with hepatocellular carcinoma (HCC). Accurate preoperative assessment of MVI and appropriate resection margins (RM) could reduce recurrence rates of HCC.
Methods: A total of 1651 eligible patients who underwent liver resection between January 1, 2018 and June 30, 2023 were retrospectively collected.
J Hepatocell Carcinoma
August 2025
Radiology Department, Beijing Youan Hospital, Capital Medical University, Beijing, People's Republic of China.
Objective: This study aimed to identify independent predictors of early recurrence (ER) and to establish a clinically applicable, individualized nomogram for patients with solitary hepatocellular carcinoma (HCC) who underwent postoperative adjuvant transarterial chemoembolization (PA-TACE).
Methods: A total of 165 patients with solitary HCC treated with PA-TACE between January 2018 and December 2022 were retrospectively analyzed. Among these patients, 71 experienced ER, while 94 remained recurrence-free for over 24 months.
JHEP Rep
September 2025
Department of Hepatic Surgery, Key Laboratory of Hepatosplenic Surgery, Ministry of Education, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Background & Aims: Microvascular invasion (MVI) is a major determinant of poor prognosis in hepatocellular carcinoma (HCC). However, reliable non-invasive biomarkers for the preoperative evaluation and diagnosis of MVI are urgently needed in clinical practice.
Methods: Plasma samples were collected from 160 patients with HCC (80 MVI-positive and 80 MVI-negative) from four medical centers.